Article
Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology - 1 Jan 2000
Thakur V, Sarin S K, Rehman S, Guptan R C, Kazim S N, Kumar S
Abstract excerpt
BACKGROUND: Predictors of response of chronic hepatitis B (CHB) to lamivudine therapy need better definition. Whether hepatitis B virus (HBV) genotypes could serve as such a predictor has not been well studied. AIM: To study the association of HBV genotypes with the outcome of lamivudine treatment in patients with CHB. METHODS: Seventy-six patients with CHB (45 HBeAg +ve) received lamivudine 100 mg/day, orally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
